Publications - Alexandra P . Wolanskyj, M.D.

Back to Research Profile

1. Pardanani A, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Hanson CA, Tefferi A. The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients. Leukemia 2009 Oct 22. [Epub ahead of print]
   View PubMed
2. Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer 2009 Oct 05. [Epub ahead of print]
   View PubMed
3. Gangat N, Tefferi A, Thanarajasingam G, Patnaik M, Schwager S, Ketterling R, Wolanskyj AP. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance. Eur J Haematol 2009 Jul; 83(1):17-21. Epub 2009 Feb 19.
   View PubMed
4. Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol 2009 May; 82(5):350-3. Epub 2009 Jan 06.
   View PubMed
5. Pardanani A, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Hanson CA, Tefferi A. The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status - clinical correlates in a study of 226 consecutive patients Leukemia (in submisison) 2009.
   View PubMed
6. Palmer SR, Thanarajasingam G, Wolanskyj AP. 39 Year-old female with an Obscure Case of Anemia. Mayo Clinic Proceedings 2009 in print.
   View PubMed
7. Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol 2008 Nov; 35(11):2165-70. Epub 2008 Oct 15.
   View PubMed
8. Spinner RJ, Vincent JF, Wolanskyj AP, Scheithauer BW. Intraneural ganglion cyst: a 200-year-old mystery solved. Clin Anat 2008 Oct; 21(7):611-8.
   View PubMed
9. Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, Mesa R, McClure RF, Li CY, Hanson CA. 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis. Eur J Haematol 2008 May; 80(5):386-90. Epub 2008 Jan 23.
   View PubMed
10. Orzechowski NM, Kumar N, Ahlskog EJ, Wolanskyj AP, Moder KG. Antiphospholipid Antibody Associated Chorea Submitted to Lupus 2008.
    View PubMed
11. Spinner RJ, Amrami KK, Wolanskyj AP, Desy NM, Wang H, Benarroch EE, Skinner JA, Rock MG, Scheithauer BW. Dynamic phases of peroneal and tibial intraneural ganglia formation: a new dimension added to the unifying articular theory. J Neurosurg 2007 Aug; 107(2):296-307.
    View PubMed
12. Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer 2007 Jun 1; 109(11):2279-84.
    View PubMed
13. Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer [Epub ahead of print] 2007 Apr 17.
    View PubMed
14. Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, Tefferi A. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia 2007 Feb; 21(2):270-6. Epub 2006 Dec 14.
    View PubMed
15. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG, Tefferi A. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006 Nov 15; 108(10):3472-6. Epub 2006 Jul 25.
    View PubMed
16. Gangat N, Wolanskyj AP, Tefferi A. Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications. Eur J Haematol 2006 Oct; 77(4):327-33. Epub 2006 Jul 19.
    View PubMed
17. Pardanani A, Ketterling RP, Li CY, Patnaik MM, Wolanskyj AP, Elliott MA, Camoriano JK, Butterfield JH, Dewald GW, Tefferi A. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res 2006 Aug; 30(8):965-70. Epub 2006 Jan 06.
    View PubMed
18. Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia. Cancer 2006 Jun 1; 106(11):2406-11.
    View PubMed
19. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 2006 Feb; 81(2):159-66.
    View PubMed
20. Wolanskyj AP, Lasho TL, Schwager SM, McClure RF, Wadleigh M, Lee SJ, Gilliland DG, Tefferi A. JAK2(V617F) mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance. Br J Haematol 2005 Oct; 131(2):208-13.
    View PubMed
21. Tefferi A, Sirhan S, Lasho TL, Schwager SM, Li CY, Dingli D, Wolanskyj AP, Steensma DP, Mesa R, Gilliland DG. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia. Br J Haematol 2005 Oct; 131(2):166-71.
    View PubMed
22. Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, Witzig TE, Micallef IN, O'Neill BP. High-dose intravenous Methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer 2004 Jun 1; 100(11):2403-7.
    View PubMed
23. Tefferi A, Lasho TL, Wolanskyj AP, Mesa RA. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood 2004 May 1; 103(9):3547-8.
    View PubMed
24. Wolanskyj AP, Schroeder G, Wilson PR, Habermann TM, Inwards DJ, Witzig TE. A randomized placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. Clin Lymphoma 2000 Sep; 1(2):154-7.
    View PubMed
25. Fervenza FC, Wolanskyj AP, Eklund HE, Richardson RL. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clin Proc 2000 Jan; 75(1):79-82.
    View PubMed
26. Enesco H, Wolanskyj AP, Sawada M. Effect of copper on lifespan and lipid peroxidation in rotifers. Age 1989; 12:9-23.
    View PubMed